Activating c‐KIT mutations contribute to leukaemogenesis by enhancing DNA repair mechanisms and inhibiting apoptosis, offering a potential mechanistic explanation for the observed chemoresistance in t(8;21) AML with cooperating c‐KIT mutations.23 This evidence concerns the gene KIT and acute myeloid leukemia.